Request Deal Involvement
Knight Therapeutics completed the acquisition of a 51.25% stake in Grupo Biotoscana from Advent and Essex Woodland for $144m.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
financial advisors
RBC Capital Markets
legal advisors
Davies Ward Phillips & Vineberg
or
Principals
target
BIOTOSCANA
vendor
ESSEX WOODLANDS HEALTH VENTURES
vendor
ADVENT INTERNATIONAL CORPORATION
bidder
KNIGHT THERAPEUTICS
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite